ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

MRTX Mirati Therapeutics Inc

58,70
0,00 (0,00%)
23 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Mirati Therapeutics Inc MRTX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 58,70 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
58,70 58,70
mais cotações »

Notícias Recentes

Data Hora Fonte Título
10/01/202410:00PRNUSEuropean Commission Approves KRAZATI (adagrasib) as a..
10/11/202309:30PRNUSMirati Therapeutics Receives Positive Opinion from CHMP for..
06/11/202310:00PRNUSMirati Therapeutics Reports Third Quarter 2023 Financial..
03/11/202318:19PRNUSMirati Therapeutics Receives Approval from the MHRA for..
02/11/202308:30GLOBEKura Oncology and Mirati Therapeutics Enter into Clinical..
17/10/202317:00PRNUSMirati Presents Late-Breaking Results Evaluating the..
09/10/202311:30DJNTrending: Bristol Myers Squibb Buying Mirati Therapeutics
09/10/202308:33IHMARKETNEWSMonday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers,..
09/10/202307:26DJNMirati Shares Slip Premarket on Bristol Myers Takeover
08/10/202319:02BWBristol Myers Squibb Strengthens and Diversifies Oncology..
08/10/202318:16BWBristol Myers Squibb Strengthens and Diversifies Oncology..
06/10/202303:56DJNSanofi Considering Acquisition of Mirati Therapeutics,..
27/09/202317:30PRNUSMirati To Present Updated Clinical Data at ESMO Congress..
09/09/202323:35PRNUSMirati Presents Two-Year Follow-Up Data from KRYSTAL-1 Study..
05/09/202317:01PRNUSMirati Therapeutics Reports Inducement Grant Under NASDAQ..
29/08/202317:00PRNUSMirati Therapeutics to Participate at the Morgan Stanley..
23/08/202317:00PRNUSMirati Therapeutics Announces Departure of Chief Financial..
21/08/202317:00PRNUSMirati To Present Pooled Clinical Data from Adagrasib's..
11/08/202317:00PRNUSMirati Therapeutics Announces Closing of Upsized Public..
09/08/202317:00PRNUSCancer Discovery Publishes Preclinical and Initial Clinical..
09/08/202301:31PRNUSMirati Therapeutics Announces Pricing of Upsized Public..
08/08/202317:02PRNUSMirati Therapeutics Announces Proposed Public Offering
08/08/202317:01PRNUSMirati Therapeutics Reports Second Quarter 2023 Financial..
08/08/202317:00PRNUSMirati Therapeutics Announces Departure of Chief Executive..
03/08/202317:01PRNUSMirati Therapeutics Reports Inducement Grant Under NASDAQ..
25/07/202317:30PRNUSMirati Therapeutics® to Report Second Quarter 2023 Financial..
21/07/202308:56PRNUSMirati Therapeutics Provides Update on Regulatory Review in..
23/06/202317:00PRNUSMirati Therapeutics Appoints Industry Veteran Carol..
20/06/202309:00PRNUSJournal of Clinical Oncology Publishes Clinical Results of..
01/06/202317:30PRNUSMirati Therapeutics to Participate at the Goldman Sachs 44th..
30/05/202317:00PRNUSMirati To Encore Compelling Clinical Data Demonstrating..

Seu Histórico Recente

Delayed Upgrade Clock